Samuel M. Poloyac

5.2k total citations
120 papers, 3.4k citations indexed

About

Samuel M. Poloyac is a scholar working on Neurology, Molecular Biology and Biochemistry. According to data from OpenAlex, Samuel M. Poloyac has authored 120 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Neurology, 29 papers in Molecular Biology and 28 papers in Biochemistry. Recurrent topics in Samuel M. Poloyac's work include Traumatic Brain Injury and Neurovascular Disturbances (34 papers), Eicosanoids and Hypertension Pharmacology (26 papers) and Cardiac Arrest and Resuscitation (20 papers). Samuel M. Poloyac is often cited by papers focused on Traumatic Brain Injury and Neurovascular Disturbances (34 papers), Eicosanoids and Hypertension Pharmacology (26 papers) and Cardiac Arrest and Resuscitation (20 papers). Samuel M. Poloyac collaborates with scholars based in United States, Italy and China. Samuel M. Poloyac's co-authors include Patrick M. Kochanek, Michael A. Tortorici, Philip E. Empey, Tricia M. Miller, Robert A. Blouin, Paula R. Sherwood, Steven H. Graham, Wen Xie, Craig R. Lee and Robert R. Bies and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Samuel M. Poloyac

118 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samuel M. Poloyac United States 36 940 790 633 624 560 120 3.4k
Yvan Gasche Switzerland 34 1.3k 1.4× 821 1.0× 66 0.1× 657 1.1× 961 1.7× 70 4.5k
Shaoqing Lei China 33 1.5k 1.5× 224 0.3× 89 0.1× 299 0.5× 439 0.8× 88 4.0k
Alex Dyson United Kingdom 28 568 0.6× 156 0.2× 312 0.5× 152 0.2× 565 1.0× 62 2.4k
Martin Hersberger Switzerland 40 1.7k 1.8× 89 0.1× 416 0.7× 140 0.2× 807 1.4× 141 5.5k
Naoyuki Matsuda Japan 35 993 1.1× 173 0.2× 78 0.1× 271 0.4× 861 1.5× 134 3.3k
John Anthony Bauer United States 38 1.5k 1.6× 129 0.2× 274 0.4× 147 0.2× 358 0.6× 139 5.3k
Muhammad M. Yaqoob United Kingdom 36 1.2k 1.3× 119 0.2× 190 0.3× 123 0.2× 391 0.7× 132 4.6k
L. Jackson Roberts United States 29 1.2k 1.2× 113 0.1× 509 0.8× 77 0.1× 295 0.5× 56 3.9k
Clive R. Pullinger United States 40 1.7k 1.8× 61 0.1× 347 0.5× 166 0.3× 753 1.3× 122 6.0k
Gaetano Serviddio Italy 49 1.5k 1.6× 132 0.2× 254 0.4× 97 0.2× 1.9k 3.3× 184 5.7k

Countries citing papers authored by Samuel M. Poloyac

Since Specialization
Citations

This map shows the geographic impact of Samuel M. Poloyac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel M. Poloyac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel M. Poloyac more than expected).

Fields of papers citing papers by Samuel M. Poloyac

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel M. Poloyac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel M. Poloyac. The network helps show where Samuel M. Poloyac may publish in the future.

Co-authorship network of co-authors of Samuel M. Poloyac

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel M. Poloyac. A scholar is included among the top collaborators of Samuel M. Poloyac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel M. Poloyac. Samuel M. Poloyac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Allen, David D., Anne Lin, Stuart T. Haines, et al.. (2024). AACP Argus Commission Forecast 2024. American Journal of Pharmaceutical Education. 88(10). 100763–100763. 4 indexed citations
2.
Osier, Nicole Danielle, Helen M. Bramlett, Deborah A. Shear, et al.. (2021). Kollidon VA64 Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy. Journal of Neurotrauma. 38(17). 2454–2472. 4 indexed citations
3.
Weeks, Daniel E., Sheila Alexander, Ryan L. Minster, et al.. (2021). Iron homeostasis pathway DNA methylation trajectories reveal a role for STEAP3 metalloreductase in patient outcomes after aneurysmal subarachnoid hemorrhage. PubMed. 1(1). 14 indexed citations
4.
Jha, Ruchira M., Stefania Mondello, Helen M. Bramlett, et al.. (2020). Glibenclamide Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy. Journal of Neurotrauma. 38(5). 628–645. 19 indexed citations
5.
Zhou, Dong, Yang Xie, You‐Jin Choi, et al.. (2020). Inhibition of Estrogen Sulfotransferase (SULT1E1/EST) Ameliorates Ischemic Acute Kidney Injury in Mice. Journal of the American Society of Nephrology. 31(7). 1496–1508. 16 indexed citations
6.
Jauhari, Abhishek, Sergei V. Baranov, Yalikun Suofu, et al.. (2020). Melatonin inhibits cytosolic mitochondrial DNA–induced neuroinflammatory signaling in accelerated aging and neurodegeneration. Journal of Clinical Investigation. 130(6). 3124–3136. 160 indexed citations
7.
Xie, Yang, Meishu Xu, Songrong Ren, et al.. (2019). Hepatic Estrogen Sulfotransferase Distantly Sensitizes Mice to Hemorrhagic Shock-Induced Acute Lung Injury. Endocrinology. 161(1). 5 indexed citations
8.
Kochanek, Patrick M., Helen M. Bramlett, C. Edward Dixon, et al.. (2018). Operation Brain Trauma Therapy: 2016 Update. Military Medicine. 183(suppl_1). 303–312. 33 indexed citations
9.
Kochanek, Patrick M., C. Edward Dixon, Stefania Mondello, et al.. (2018). Multi-Center Pre-clinical Consortia to Enhance Translation of Therapies and Biomarkers for Traumatic Brain Injury: Operation Brain Trauma Therapy and Beyond. Frontiers in Neurology. 9. 640–640. 34 indexed citations
10.
Clark, Robert S. B., Philip E. Empey, Hülya Bayır, et al.. (2017). Phase I randomized clinical trial of N-acetylcysteine in combination with an adjuvant probenecid for treatment of severe traumatic brain injury in children. PLoS ONE. 12(7). e0180280–e0180280. 40 indexed citations
11.
Jha, Ruchira M., Ava M. Puccio, Sherry Chou, et al.. (2016). Sulfonylurea Receptor-1 as a Novel Biomarker for Cerebral Edema in Patients with Severe Traumatic Brain Injury (S46.001). Neurology. 86(16_supplement). 1 indexed citations
12.
Crago, Elizabeth, Yvette P. Conley, Dianxu Ren, et al.. (2015). 20-HETE is Associated with Unfavorable Outcomes in Subarachnoid Hemorrhage Patients. Journal of Cerebral Blood Flow & Metabolism. 35(9). 1515–1522. 29 indexed citations
13.
Tyurina, Yulia Y., Samuel M. Poloyac, Vladimir A. Tyurin, et al.. (2014). A mitochondrial pathway for biosynthesis of lipid mediators. Nature Chemistry. 6(6). 542–552. 128 indexed citations
14.
Empey, Philip E., Nieves Vélez de Mendizábal, Michael J. Bell, et al.. (2013). Therapeutic Hypothermia Decreases Phenytoin Elimination in Children with Traumatic Brain Injury*. Critical Care Medicine. 41(10). 2379–2387. 36 indexed citations
15.
Zhou, Tianhua, et al.. (2013). Short Communication: Expression of Transporters and Metabolizing Enzymes in the Female Lower Genital Tract: Implications for Microbicide Research. AIDS Research and Human Retroviruses. 29(11). 1496–1503. 41 indexed citations
16.
Hostler, David, Michael A. Tortorici, Robert R. Bies, et al.. (2010). Mild Hypothermia Alters Midazolam Pharmacokinetics in Normal Healthy Volunteers. Drug Metabolism and Disposition. 38(5). 781–788. 60 indexed citations
17.
Feng, Yan, et al.. (2005). Determination of 13-O-demethyl tacrolimus in human liver microsomal incubates using liquid chromatography–mass spectrometric assay (LC–MS). Journal of Chromatography B. 821(1). 31–37. 6 indexed citations
18.
Warren, Graham, Samuel M. Poloyac, Devin S. Gary, Mark P. Mattson, & Robert A. Blouin. (1999). Hepatic cytochrome P-450 expression in tumor necrosis factor-alpha receptor (p55/p75) knockout mice after endotoxin administration.. PubMed. 288(3). 945–50. 59 indexed citations
19.
Warren, Graham, Samuel M. Poloyac, Devin S. Gary, Mark P. Mattson, & Robert A. Blouin. (1999). Hepatic Cytochrome P-450 Expression in Tumor Necrosis Factor-α Receptor (p55/p75) Knockout Mice After Endotoxin Administration. Journal of Pharmacology and Experimental Therapeutics. 288(3). 945–950. 30 indexed citations
20.
Frye, Reginald F., et al.. (1992). Pharmacodynamic modeling of erythropoietin therapy. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 12(6). 504.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026